HomePGEN • NASDAQ
Follow
Precigen Inc
Previous close
$1.45
Day range
$1.42 - $1.47
Year range
$0.84 - $1.88
Market cap
360.93M USD
Avg Volume
1.16M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.23M | -30.35% |
Operating expense | 10.26M | -10.82% |
Net income | -33.06M | -49.06% |
Net profit margin | -2.69K | -114.00% |
Earnings per share | -0.09 | 19.91% |
EBITDA | -21.78M | -31.95% |
Effective tax rate | 0.99% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 62.86M | 12.34% |
Total assets | 151.04M | -30.07% |
Total liabilities | 32.54M | -63.73% |
Total equity | 118.50M | — |
Shares outstanding | 248.92M | — |
Price to book | 3.02 | — |
Return on assets | -34.22% | — |
Return on capital | -41.67% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -33.06M | -49.06% |
Cash from operations | -15.77M | -2.40% |
Cash from investing | 13.29M | 16.39% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -2.49M | 94.25% |
Free cash flow | -8.35M | -123.68% |
About
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Founded
May 21, 1998
Website
Employees
202